A Federal Court judge has awarded combined damages of $2.6 million to the lead applicants in the Johnson & Johnson pelvic mesh class action, following a landmark ruling in November which found that the pharmaceutical giant did not adequately warn of the risks of the implants.
An individual claimant accusing AMP Financial Planning of ignoring multiple attempts to gain remediation for alleged insurance re-writing conduct was granted permission to voice his displeasure in court, while ASIC and AMP grapple with the details of a remediation program for insurance churn victims.
Two executives of car wash franchisor Geowash that were found to be knowingly involved in the company’s unconscionable conduct in its dealings with franchisees have lost their bid to void a costs agreement with law firm Thomson Geer, with a judge calling legal cost estimations “an inexact science”.
A company owned by Clive Palmer is appealing a ruling that denied its bid to temporarily block funding for a class action over the troubled Coolum Palmer Resort.
The Federal Court judge overseeing three class actions against the Commonwealth of Australia over allegedly toxic firefighting foam has questioned the terms of the in-principle settlement reached last week, including whether the settlement amount should remain confidential.
The ACCC has asked for an interim stay of an appeal by Indonesian airline Garuda, which has yet to pay a $19 million penalty for airline price fixing, telling the court it wanted to give the company another chance to explain its “entirely exceptional” non-compliance.
The Australian Stock Exchange has denied claims by ISignthis that it suspended the fintech company’s shares without warning and at the direction of ASIC, but has admitted that it told the company it would consult with the securities regulator before lifting the ongoing suspension.
Property listing startup Zango has denied claims by listing giant Domain that its ads misleadingly represented that it will have listings before any of its rivals, saying the ads amounted to “puffery” but admitting that it self-reported the matter to the ACCC.
A judge has granted a request by Otsuka and Bristol-Myers Squibbs to withdraw admissions in proceedings brought by Generic Health seeking damages, after the generic drug maker was temporarily blocked from selling a generic version of antipsychotic Abilify in a patent dispute in which it ultimately triumphed.
Farmers in a class action against Advanta Seeds over allegedly contaminated sorghum have defeated a bid by the company to hand over a list of all group members who have signed funding agreements to join the case.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
